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ABSTRACT 30 
This study examined the prevalence and correlates of use of complementary and alternative 31 
medicine (CAM) among a sample of children with autism spectrum disorder (ASD) < 7 years 32 
in 18 European countries (N=1,680).  Forty seven percent of parents reported having tried 33 
any CAM approach in the past 6 months.  Diets and supplements were used by 25% of the 34 
sample and mind-body practices by 24%; other unconventional approaches were used by 35 
25% of the families; and a minority of parents reported having tried any invasive or 36 
potentially harmful approach (2%).  Parents in Eastern Europe reported significantly higher 37 
rates of CAM use.  In the total sample, children with lower verbal ability and children 38 
concurrently using prescribed medications were more likely to be receiving diets or 39 
supplements.  Concurrent use of high levels of conventional psychosocial intervention was 40 
significantly associated with use of mind-body practices.  Higher parental educational level 41 
also increased the likelihood of both use of diets and supplements and use of mind-body 42 
practices.  Conclusion: The high prevalence of CAM use among a sample of young children 43 
with ASD is an indication that parents need to be supported in the choice of treatments early 44 
on in the assessment process, particularly in some parts of Europe. 45 
 46 
   47 
    48 
  49 
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 50 
Introduction 51 
Autism spectrum disorder (ASD) is a behaviourally defined disorder characterized by 52 
impairments in social communication abilities and the presence of restricted and repetitive 53 
behaviours and atypical sensory responses [3].  Despite the evidence that behavioural and 54 
social communication interventions can ameliorate symptoms and improve outcomes [29] it 55 
is not a condition for which a ‘cure’ is currently available.  The uncertainty concerning the 56 
developmental outcomes, the limitations to existing treatments, and the lack of a simple cure 57 
have been indicated as possible reasons for the high prevalence of use of therapies based 58 
outside the domain of conventional medical and psychological practice by families of 59 
children with autism [21].  Such therapies, generally defined as complementary and 60 
alternative medicine (CAM), comprise a myriad of “interventions” that range from unproven 61 
and untested treatments to approaches that have been found to be harmful.  The National 62 
Center for Complementary and Alternative Medicine (NCCAM) distinguishes the following 63 
broad areas of CAM: ‘natural products’ (often sold as dietary supplements), ‘mind and body 64 
practices’ (such as massage or sensory integration therapy) and a residual category of other 65 
complementary health approaches that do not fit neatly in the previous ones, such as 66 
homeopathy (http://nccam.nih.gov/).  Research on CAM use broadly refers back to this 67 
classification, but additional meaningful categories of CAM such as “invasive or potentially 68 
unsafe approaches" [1] and other unconventional approaches that are not strictly classifiable 69 
as CAM (such as pet therapy) are also often included in such surveys.  This, and the fact that 70 
the NCCAM classification has changed over time, have led to some inconsistency across 71 
studies.   72 
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The efficacy of CAM treatment is controversial, but for most of these approaches 73 
there simply is not enough evidence to evaluate them [23].  For example, while gluten- and 74 
casein-free diets are widely used and reported to be efficacious by parents [40], to date only 75 
two RCTs have tested their efficacy, yielding mixed results that prevent any recommendation 76 
of these exclusion diets as standard treatments [19,8].  Omega-3 fatty acids are increasingly 77 
used in ASD despite lack of understanding on which might be the optimal dosage and 78 
insufficient evidence of efficacy [18].  Moreover, while CAM is often used in combination 79 
with medication, little is known about potential aversive effects of the interaction between 80 
drugs and supplements, which requires careful monitoring [20].  There is some positive 81 
evidence for some CAM approaches, such as horse-riding [16] and massage [34].  A 82 
Cochrane review of auditory integration training, a costly and theoretically ill-specified 83 
treatment, did not find sufficient evidence to support its use [35].  84 
In US based samples, there is some evidence that CAM use in children or young 85 
people with ASD is associated with greater functional difficulty [15,32,38], but this has not 86 
always been replicated [1].  A higher parental educational level and high levels of use of 87 
conventional therapy (>20 hours) have also been found to be associated with CAM use in 88 
children with ASD [1].  Cultural and systemic factors (such as families’ own recognition and 89 
beliefs around aetiology and course of symptoms as well as the actual availability of 90 
conventional therapy) might also play a role in the decision to use CAM [25].  Professionals’ 91 
opinions vary widely on the topic [31] and might be another source of influence on family 92 
choice.  These aspects are likely to differ in different parts of the world [4], however with the 93 
exception of a non-systematic review based on professionals’ opinions [41] no studies to date 94 
report on the use of CAM in Europe. Moreover, different factors might play a different role in 95 
use of specific types of CAM, but this is only beginning to be addressed [32].  The present 96 
study aimed at describing the prevalence of use of CAM in Europe, as well as identifying the 97 
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correlates of use of the two main classes of CAM: diets and supplements and mind-body 98 
practices.   99 
Methods 100 
Ethical approval was given by the Research Ethics Committee of the Faculty of 101 
Children and Learning, Institute of Education, London, UK. Parents provided informed 102 
consent before completing the survey (IOE/ FPS 385). 103 
Survey 104 
The present study focuses on a set of questions on use of CAM that was part of a 105 
wider-scope survey on use of interventions in Europe [33, in press].  The survey was open for 106 
completion for 45 days. A total of 1,680 families with a child with ASD aged 7 or younger in 107 
18 countries completed the online survey: Belgium, Czech Republic, Denmark, Finland, 108 
France, Germany, Hungary, Iceland, Ireland, Italy, Netherlands, Norway, Poland, Portugal, 109 
Romania, Spain, The Former Yugoslav Republic of Macedonia and the United Kingdom.  110 
Participants were recruited via national parents’ associations who advertised the link on their 111 
websites, with the exception of parents in The Former Yugoslav Republic of Macedonia who 112 
were recruited through the Paediatric Clinic of Skopje in absence of a national parents’ 113 
association and completed a paper version of the survey.  Before launching the survey, the 114 
questionnaire was piloted with parents from the UK (N=8) and Italy (N=2); as a result of the 115 
pilot, the possibility to select a generic intervention if the nature of the approach was not 116 
known to the parent was further highlighted in the initial instructions. Participant 117 
characteristics are summarised in Table 1.   118 
Parent characteristics: General background information on respondents was 119 
gathered: relationship to child (mother/father/other) and educational level (below high school 120 
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diploma, high school diploma, bachelor/degree, postgraduate).  The educational level was 121 
collapsed for analysis into the following two categories: low educational level (up to high 122 
school diploma, 37%) and high educational level (degree and postgraduate, 63%).  To 123 
comply with the relevant legislation on cross-national sharing of sensitive personal data in 124 
some of the participating countries, parents were asked to report on the country of residency 125 
but data on nationality and ethnicity were not collected. 126 
Child characteristics: Information on the age of the child at survey completion was 127 
collected and dichotomised to reflect the age at which typically children start school in 128 
Europe (below age 5, 52% and 5 years and above, 48%). Child verbal ability was rated by 129 
parents selecting one of five options (does not talk; uses single words; uses two- or three-130 
word phrases; uses sentences with four or more words; uses complex sentences).  The options 131 
were collapsed into two categories for the purposes of analysis: low verbal ability (non-verbal 132 
or single words speech, 37%) and use of at least phrase speech (63%).   133 
Use of conventional therapies and prescription medication: Parents were asked to 134 
report on current use of conventional behavioural, developmental and psychosocial 135 
intervention (such as applied behavioural analysis, occupational therapy, speech and language 136 
therapy…) and medication.  A total of 1,529 parents (91%) reported using at least one 137 
conventional intervention.  The number of conventional interventions used ranged from 1 to 7 138 
(M=2.39, SD=1.43; IQR: 1-3); more detailed results are reported in [33, in press]. For the 139 
purposes of this analysis, we classified the sample for level of use of conventional treatments.  140 
Three levels of use were defined based on the distribution of number of interventions used: 141 
no use (0 therapies used; 9%), medium level of use (use of 1-3 therapies; 70.5%) and high 142 
level of use (use of 4 or more therapies; 20.5%).  Parents reported using at least one 143 
medication in 19.7% of cases in the total sample. Use of medication was dichotomised for 144 
this analysis into a “use of any medication” binary variable.  145 
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CAM: A list of CAM approaches was drawn from the literature.  Parents were asked 146 
to endorse all the approaches that they had used with their child in the previous 6 months.  147 
The CAM approaches, listed alphabetically in the form, were successively classified into four 148 
categories for the purpose of statistical analysis: the three categories proposed by the 149 
NCCAM (diets and supplements; mind and body practices; other unconventional approaches) 150 
and a fourth category of “invasive, disproven or potentially unsafe CAM” (including 151 
chelation, hyperbaric oxygen therapy and packing) which was added [following 1].   152 
 153 
Data analysis 154 
Descriptive statistics were used to report on use of each CAM approach, grouped in 155 
four over-arching categories.  Prevalence of use of these categories was examined in the total 156 
sample and by European regions [37]: Western Europe (Belgium, France, Germany and 157 
Netherlands), Northern Europe (Denmark, Finland, Iceland, Ireland, Norway, United 158 
Kingdom), Eastern Europe (Czech Republic, Hungary, Poland, Romania) and Southern 159 
Europe (Italy, Macedonia, Portugal, Spain).   160 
To investigate the association of child and parental characteristics with use of CAM, 161 
we conducted logistic regressions on the total sample for two primary outcomes: use of any 162 
diets or supplements and use of any body-mind practices.  These categories were selected for 163 
the analysis on the basis of the following criteria: conceptual relevance, homogeneity of 164 
approaches included and frequency of use.  In each model, the predictors were: child’s 165 
gender, verbal ability and age, parental educational level, use of any prescription medication, 166 
use of conventional therapies categorised into three dummy variables (no use of therapy, 167 
medium level of use, and high level of use; the first category was used as the reference). 168 
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Results 169 
---- Table 1 about here ----- 170 
Frequency of CAM 171 
Frequency of use of individual CAM approaches is reported in Table 2.  A total of 172 
789 respondents (47%) reported using at least one type of CAM.  The rate of use of any 173 
CAM was significantly higher in Eastern (66%) than in Western (41%, p<.001), Northern 174 
(46%, p<.001) and Southern (40%, p<.001) Europe.  The prevalence of use in Northern 175 
Europe was also significantly higher than in Southern Europe (p=.038).  In the total sample, 176 
the most commonly used CAM approaches were diets and supplements (24.4% reported 177 
using any); use of vitamins was reported by 259 parents (15.4%) and gluten or casein free 178 
diets were reported by 227 (13.5%).  The proportion of parents reporting using diets and 179 
supplements was significantly higher in Eastern Europe (38%) than in Western (17%, 180 
p<.001), Northern (28%, p=.003) and Southern Europe (20%, p<.001). Reported use in 181 
Northern Europe was also significantly higher than use in Western (p<.001) and Southern 182 
Europe (p=.007).  Mind and body practices were reported by 395 respondents in the total 183 
sample (23.5%); among these, sensory integration therapy (13.6%) and massage (7.1%) were 184 
the most commonly used treatments.  Parents in Eastern Europe also reported the highest rate 185 
of use of any mind-body practices (34%); this proportion was significantly higher than rates 186 
in Western (20%, p<.001), Northern (28%, p=.043) and Southern Europe (16%, p<.001).  187 
Reported use of mind-body practices in Northern Europe was also significantly higher than in 188 
Southern (p<.001) and Western Europe (<.006).  A number of other unconventional 189 
approaches not included in the previously mentioned classes of CAM were reported in 24.5% 190 
of the total sample (n=514): among these, pet therapy (n= 233, 13.9%) and homeopathy 191 
(n=161, 9.6%) were the most widely used.   The proportion of parents reporting using such 192 
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approaches was significantly higher in Eastern Europe (43%) than in Western (24%, p<.001), 193 
Northern (12%, p<.001) and Southern Europe (19%, p<.001). Reported use in Western and 194 
Southern Europe was also significantly higher than in Northern Europe (p<.001 and p=.006).  195 
A small minority of parents (n=40, 2.4%) reported using any invasive, disproven or 196 
potentially unsafe CAM (chelation, hyperbaric chamber and packing).  Rate of use of such 197 
approaches was significantly higher in Eastern Europe (5%) than in Western (0.8%, p<.001), 198 
Northern (1.5%, p=.006) and Southern Europe (2.5%, p=.037).  The rate in Southern Europe 199 
was also significantly higher than the rate in Western Europe (p=.034).  The total number of 200 
different CAM approaches used for those parents who used any CAM approaches ranged 201 
from 1 to 12 with a mean of 2.15 (SD=1.55, IQR: 1-3) in the total sample.  A significant 202 
effect of European region was found on number of CAM approaches used, F (3, 785) = 9.72, 203 
p<.001, ω=.18.  Post hoc comparisons indicated that the mean number of approaches used 204 
with children living in Eastern Europe (M = 2.60, SD = 1.87, IQR: 1-3) was significantly 205 
higher than the mean number of approaches used with children living in Western Europe (M 206 
= 1.92, SD = 1.40, IQR: 1-2; p<.001), Northern Europe (M = 2.06, SD = 1.22, IQR: 1-3; 207 
p=.004) and Southern Europe (M = 1.93, SD = 1.42, IQR: 1-2; p<.001).   208 
----- Table 2 about here ----- 209 
Predictors of CAM use 210 
Logistic regression models were performed on the total sample with use of any 211 
diets/supplements and use of any mind-body practice as outcome variables.  Table 3 reports 212 
the odds ratios and 95% CIs for the predictors of each logistic regression model.  For all 213 
models, the χ² statistics were significant (all p < .001) and the Hosmer & Lemeshow’s 214 
goodness-of-fit tests [17] were not significant (hence indicating well-fitting models).  The 215 
Nagelskerke’s R2 [27] were low (range .03-.08), which is an indication that several other 216 
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relevant variables had not been included in the model.  For each predictor, the effects 217 
reported below are intended to be over and above the effect of all other variables included in 218 
the model.  219 
----- Table 3 ----- 220 
Use of any diets/supplements 221 
Use of any diets or supplements was significantly associated with low verbal ability in 222 
the children and higher parental educational level.  Use of prescription medication increased 223 
the likelihood of using diets or supplements by 62%.  Child’s gender and age and use of 224 
conventional therapy were not predictors of using diets or supplements.   225 
Use of any mind-body practices 226 
Mind and body practices were less likely to being used with boys than with girls.  A 227 
higher parental educational level and high levels of use of conventional psychosocial 228 
interventions were associated with concurrent use of mind-and-body practices.  Child’s age 229 
and verbal ability, use of medication and medium levels of use of conventional treatments 230 
were not associated with use of this category of CAM.  231 
Discussion 232 
This study is the first to report on use of CAM in young children with autism in 233 
Europe.  We found that overall 47% of parents reported using at least one type of CAM or 234 
other unconventional treatment in the previous 6 months.  Rates of use were homogeneous 235 
across Europe with the exception of significantly higher rates in Eastern Europe (66%).  236 
Prevalence data from US samples obtained from reviews of patients charts vary from 30-50% 237 
[21,32,1] to 70-90% [14,15].  In the total sample, parents reported using diets or supplements 238 
in 24% of cases.  Previous reports of use of diets ranged 27%-42% [11,13,15], but 239 
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comparisons are made difficult by the different level of detail across studies.  A similar 240 
proportion of parents in our total sample reported using mind-body practices (24%).  Rates 241 
from previous studies ranged 20-30% [15,14], but comparison should be made with caution 242 
as different definitions were used or CAM approaches were considered individually rather 243 
than as a class.   244 
We also enquired about some invasive or potentially harmful treatments: chelation, 245 
hyperbaric chamber and packing.  Chelation is medical procedure involving administering 246 
various chemical substances for the purpose of binding and then withdrawing specific metals 247 
from the person's body; its potential serious side effects (including death) and the lack of 248 
sound scientific rationale argue against its therapeutic use [6].  Hyperbaric oxygen therapy 249 
involves breathing oxygen in a pressurized chamber for the purpose of increasing the amount 250 
of oxygen in the blood; it is both ineffective [12] and unsafe (potential side effects include 251 
paralysis and air embolism).  Packing involves wrapping the individual in towels previously 252 
wet in cold water to supposedly reinforce the individuals’ consciousness of their bodily 253 
limits; this practice, which appears to be a clear violation of human rights, has not been 254 
evaluated systematically [7].  In our sample, 40 parents (2%) reported using any of these 255 
treatments with their children. 256 
Among the other unconventional treatments included in the survey, it is relevant to 257 
note the high prevalence of reported use of pet therapy (14%).  Pet-therapy is a generic term 258 
that encompasses both the use of “assistance” pets (i.e., placement of a pet in the family) and 259 
the use of “therapy” pets by a therapist at home or in other settings; it is not possible to know 260 
whether in our sample parents were endorsing the former or the latter.  Higher figures (24%) 261 
have been reported before [5].  262 
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There were significant regional differences in the rates of use of the four over-arching 263 
categories of CAM, with consistently higher rates in Eastern Europe than in the rest of 264 
Europe.   This might be due to lack of access to evidence-based information in those 265 
countries, possibly as a residual consequence of the historical divide on health policies in 266 
Europe [24] or to cultural differences in attitudes of professionals and community members 267 
that are only beginning to be explored [41].  268 
We were interested in identifying correlates of use of CAM in Europe. As CAM is 269 
comprised of a plethora of different types of “treatments”, we investigated correlates of use 270 
of the two main classes of approaches, selected for their conceptual relevance and relative 271 
homogeneity: diets and supplements and mind-body practices.  No gender differences were 272 
found for use of diets and supplements. There was a tendency for more mind-body practices 273 
to be used with girls than with boys, but this finding should be interpreted with caution as the 274 
females in the sample were only a minority (n=291, 18%).  In our sample, non-verbal 275 
children and children with single-words speech were more likely to being treated with diets 276 
(30% increase in the probability of use), suggesting that parents of lower functioning children 277 
may tend to look to a range of interventions to respond to more severe difficulties. 278 
Additionally, over and above the effect of verbal ability, children using prescription 279 
medication were also more likely to be treated with diets than children not using medication 280 
(62% increase).  Interestingly though, neither of these associations was found for use of 281 
mind-body practices.  This suggests that previous evidence of higher use of CAM in low 282 
functioning children [32,14] might be specific to some CAM types.  The association of use of 283 
medication with use of diets but not mind-body practice might be due to the use of 284 
supplements or alterations in the diet as an attempt to counter-balance potential side effects of 285 
medications or to “boost” their efficacy [15].  Alternatively, the association could reflect 286 
parental attitudes or beliefs (e.g., a generic belief in chemical/biological mechanisms) or the 287 
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willingness of the child to orally intake pills or tablets.  Increased diet use in children 288 
concurrently taking medications may also reflect an attempt to counteract the weight-gain 289 
associated with many psychotropic medications, although we did not ask parents to report 290 
why their child was on a diet, which should be done in future studies.  In addition, we do not 291 
have information on whether diets or supplements were medically prescribed as a treatment 292 
for specific conditions (such as iron deficiency).    293 
Parents with a high educational level have been consistently reported in previous 294 
studies to be more likely to use CAM than parents with a lower educational level [14,1] and 295 
in our study more educated parents were more likely to choose diets or supplements for their 296 
child as well as using mind-and body practices.  Notably, the increase in the likelihood was 297 
higher for the mind-body practices (64%) than diets and supplements (35%). Mind-and-body 298 
practices are practitioner-delivered and their cost is on average almost double the cost of self-299 
care therapies such as supplements [28], and this might explain why in our sample mind-and-300 
body practices were significantly less used by parents with a lower SES (indexed by their 301 
educational level).  302 
When the correlation of CAM use and use of conventional treatments has been 303 
explored, it appears that availability and use of conventional treatments does not lessen use of 304 
CAM.  Indeed, CAM use has been found to be associated with receiving 20 or more hours 305 
per week of conventional treatment [1].  Here, we explored the association between use of 306 
conventional treatments and use of two specific classes of CAM.  There was no association 307 
between use of conventional treatment and use of diets: the use of such approaches might in 308 
fact be more related to the use of medications, as suggested above.  We found instead a large 309 
dose-response effect of use of conventional treatments on use of mind-body practices with a 310 
four-fold increase in the likelihood of concurrent CAM use for parents reporting already 311 
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using more than four conventional treatments for their child, but not for medium levels of 312 
treatment (up to three interventions).   313 
This finding suggests that use of mind-body practices is most strongly related with a 314 
tendency to try a wide number of approaches; this might indicate that some parents, over and 315 
above the effect of their child’s level of functioning (measured as verbal ability) and of their 316 
own educational level (which can be constructed as a proxy of their SES), tend to look for as 317 
many therapies as possible, whether these be conventional treatments or CAM approaches.  318 
Use of diets appeared to be most strongly associated with lower functioning of the child and 319 
concurrent use of prescription medication.   320 
There is concern that desperate parents may resort to unsafe or disproven CAM 321 
approaches and public agencies have been actively campaigning against them [10], but such 322 
approaches were not in wide use in our sample. However, animal-assisted therapy, whose 323 
efficacy is not yet established, is attracting increasing interest [30] and a considerable number 324 
of parents reported using such approaches in our sample.  These findings have implications 325 
for clinicians and professionals involved in the care of children with ASD, in that they should 326 
engage parents in frank discussions about CAM approaches, the available evidence and any 327 
potential for adverse effects.   328 
Strengths and limitations  329 
There are a number of strengths to the present study, including the large sample size 330 
and the wide scope of the survey, which enquired about the use of a range of both CAM 331 
approaches and conventional treatments for young children with autism in Europe.  332 
Moreover, while previous research has looked at predictive factors for use of CAM 333 
considering child and parent characteristics as individual factors or only adjusting for parental 334 
education level, in our study we used multiple logistic regression to estimate the contribution 335 
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of each predictor having taken into account the influence of the other factors. These findings 336 
can help to identify families potentially more likely to adopt CAM approaches, and this 337 
information may be beneficial both to primary care providers in their role as clinical advisors, 338 
and to researchers, for example when designing trials of CAM approaches.  339 
Nevertheless, the findings should be seen in the context of some limitations.  Firstly, 340 
we employed a recruitment method (online survey advertised via parents’ associations) that 341 
might have been prone to selection bias since parents involved in associations are more likely 342 
to have a relatively high income and educational level [26] and internet access is still a 343 
function of socio-demographic characteristics in Europe [39].  Our sample had in fact a 344 
higher than average education level [9].  However, while the recruitment strategy used 345 
necessarily prevents any claims of generalizability of our results to the European population, 346 
it has enabled us to reach a large number of families across Europe.  Moreover, it has been 347 
argued that, given the controversy around use of CAM, an anonymous online survey might 348 
actually better protect against the potential risks of selection and reporting bias [36], than 349 
when parents are directly asked by clinicians (as happened in most other studies on the topic).  350 
Furthermore, we found that reported levels of CAM use in the present study were similar to 351 
previous studies in non-EU samples. 352 
The factors examined in the present study are only some of the many that might affect 353 
the decision-making process underlying the choice of using CAM alongside (or alternative 354 
to) conventional healthcare, which is still largely unexplained.  For example, there is 355 
preliminary evidence from a small sample of French parents (N=89) that personality 356 
characteristics such as personal control and attribution of cause of autism affect the decision 357 
to use CAM or not [2].  Parents’ own use of CAM is likely to be a relevant factor but has 358 
never been examined in the association with use of CAM in children.  Further research on the 359 
topic should include these and other factors, such as beliefs on ASD aetiology, to better 360 
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understand the phenomenon of use of CAM for children with autism. Finally, reliance on 361 
parent report in absence of direct assessments places a limitation on these findings in relation 362 
to severity of child symptoms and behavioural characteristics. 363 
Conclusions 364 
This was the first study to report on factors associated with use of CAM in a large 365 
sample of young children with autism in Europe. While little is known on the efficacy (and 366 
conversely, on the potential harm) of CAM approaches, a vast amount of uncontrolled 367 
information is available on-line, putting parents at risk of embarking in sometimes costly and 368 
often non-efficacious treatments.  Rates of CAM use, including use of disproven or unsafe 369 
approaches, were particularly high in Eastern Europe.  The present study contributed to the 370 
understanding of the factors associated to use of CAM and provided some evidence that 371 
families that tend to use a wide range of conventional treatments might also be more likely to 372 
be trying some CAM approaches.  The reasons behind this are not fully understood, and may 373 
reflect factors that were not captured by the present study.  Nonetheless these findings, taken 374 
together with the evidence of socio-economic barriers in access to treatment for autism 375 
[22,33, in press], provide some insight into the lengths to which families may go in pursuit of 376 
ways to help their child progress.  The findings highlight the need to further advance research 377 
funding and policy development for evidence-based early interventions for children with 378 
ASD across Europe.  379 
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